PharmaCyte Biotech, Inc. PMCB US Equity
$0.52
-0.03 (-4.66%)
USD · as of 2026-08-28 · marketstack
PharmaCyte Biotech, Inc. (Nasdaq: PMCB), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $0.52, -4.7%, on 2026-08-28, with a market cap of $6M as of 2026-08-27, a trailing P/E of 0.2 and a return on equity of 77.1%. Institutional ownership, earnings history and filed financials are on the tabs below.
| Date | Event | What happened / filer | Source |
|---|---|---|---|
| No 8-K or Schedule 13D/G filings on record for PMCB in the collected window (US SEC filers only). | |||
Source: SEC EDGAR (public domain)
Every row is a filed document, checked against its EDGAR index.